Aster DM Healthcare Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Aster DM Healthcare Share Price

814.951.21 (0.15%)

Closed
As On: 12 Jun, 2026, 03:58 PM IST
As On: 12 Jun, 2026, 03:52 PM IST

Sector: Hospitals & All...
Industry: Hospital

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	835.00
High	836.50
Low	806.05
Prev Close	813.75
Volume	11,81,355
VWAP(₹)	820.84

Key Metrics

PE Ratio(x)	108.79
EPS - TTM(₹)	7.49
MCap(₹ Cr.)	42,224.27
MCap Rank	4
PB Ratio(x)	8.71
Div Yield(%)	-
Face Value(₹)	10.00
52W High(₹)	836.50
52W Low(₹)	519.10
MCap/Sales	7.49
Beta(1 Month)	1.70
BV/Share(₹)	93.29

Aster DM Health share price insights

Rank 256 - ET 5002025 ranking

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.25% outperformed its 3 year CAGR of -26.28%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.65% of its operating revenues towards interest expenses and 18.27% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Aster DM Health Share Price Update
Aster DM Healthcare Ltd. share price moved up by 0.15% from its previous close of Rs 813.75. Aster DM Healthcare Ltd. stock last traded price is 814.95
Share Price Value
Today/Current/Last 814.95814.95
Previous Day 813.75814.20

Found Insights useful?

Aster DM Health Share Price Returns

1 Day	0.15%
1 Month	11.58%
3 Months	19.14%
1 Year	44.41%
3 Years	192.1%
5 Years	402.13%

Aster DM Health Share Recommendations

Mean recosCurrent

BUY

10 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	3	3	3	3
Buy	7	7	7	6
Hold	-	-	-	-
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	10	10	10	9

Recent Recos

Target₹532
OrganizationJM Financial
BUY

Target₹400
OrganizationPrabhudas Lilladher
BUY

Target₹430
OrganizationPrabhudas Lilladher
BUY

View all Stock Recommendations

News & Analysis

View all Aster DM Health Share News & Announcements

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	1,218.58	1,213.73	1,225.46	1,111.05	1,031.62
Total Income Growth (%)	0.40	-0.96	10.30	7.70	-4.73
Total Expenses	1,016.71	1,070.47	1,013.85	938.12	898.64
Total Expenses Growth (%)	-5.02	5.58	8.07	4.39	-5.06
EBIT	201.87	143.26	211.61	172.93	132.98
EBIT Growth (%)	40.91	-32.30	22.37	30.04	-2.39
Profit after Tax (PAT)	140.17	52.45	110.00	85.52	79.02
PAT Growth (%)	167.24	-52.32	28.62	8.23	39.14
EBIT Margin (%)	16.57	11.80	17.27	15.56	12.89
Net Profit Margin (%)	11.50	4.32	8.98	7.70	7.66
Basic EPS (₹)	2.72	1.02	2.13	1.67	1.59

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	695.65	697.16	726.45	651.47	608.99
Total Income Growth (%)	-0.22	-4.03	11.51	6.98	-0.75
Total Expenses	632.03	583.95	571.48	521.80	523.14
Total Expenses Growth (%)	8.23	2.18	9.52	-0.26	-0.11
EBIT	63.62	113.21	154.97	129.67	85.85
EBIT Growth (%)	-43.80	-26.95	19.51	51.04	-4.48
Profit after Tax (PAT)	27.46	55.16	104.61	80.59	61.07
PAT Growth (%)	-50.22	-47.27	29.81	31.96	22.58
EBIT Margin (%)	9.15	16.24	21.33	19.90	14.10
Net Profit Margin (%)	3.95	7.91	14.40	12.37	10.03
Basic EPS (₹)	0.53	1.07	2.04	1.58	1.23

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	4,768.82	4,286.69	3,723.75	12,011.13	10,303.94
Total Revenue Growth (%)	11.25	15.12	-69.00	16.57	19.01
Total Expenses	4,129.42	3,746.58	3,451.22	11,477.27	9,667.63
Total Expenses Growth (%)	10.22	8.56	-69.93	18.72	14.32
Profit after Tax (PAT)	388.14	5,377.83	129.28	424.91	525.99
PAT Growth (%)	-92.78	4,059.83	-69.57	-19.22	256.02
Operating Profit Margin (%)	16.41	16.04	10.34	7.23	8.71
Net Profit Margin (%)	8.35	129.94	3.49	3.56	5.12
Basic EPS (₹)	7.53	107.98	2.60	8.54	10.58

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,770.73	8,059.15	2,085.52	1,583.51	1,198.67
Total Revenue Growth (%)	-65.62	286.43	31.70	32.11	56.04
Total Expenses	2,306.61	2,094.05	1,876.17	1,401.18	1,108.71
Total Expenses Growth (%)	10.15	11.61	33.90	26.38	32.59
Profit after Tax (PAT)	267.82	6,208.97	156.96	173.29	90.18
PAT Growth (%)	-95.69	3,855.77	-9.42	92.16	-
Operating Profit Margin (%)	21.08	260.75	14.12	15.26	12.00
Net Profit Margin (%)	10.23	267.57	7.70	11.29	8.07
Basic EPS (₹)	5.20	124.67	3.15	3.48	1.81

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.25% outperformed its 3 year CAGR of -26.28%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 2.65% of its operating revenues towards interest expenses and 18.27% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	8,111.96	6,606.38	17,991.31	14,881.20	12,546.24
Total Assets Growth (%)	22.79	-63.28	20.90	18.61	7.75
Total Liabilities	3,278.26	2,954.93	12,961.20	10,020.74	8,063.62
Total Liabilities Growth (%)	10.94	-77.20	29.34	24.27	3.26
Total Equity	4,833.70	3,651.45	5,030.11	4,486.08	4,482.62
Total Equity Growth (%)	32.38	-27.41	12.13	0.08	16.91
Current Ratio (x)	1.99	2.16	1.25	1.06	1.15
Total Debt to Equity (x)	0.15	0.19	0.15	0.56	0.55
Contingent Liabilities	0.00	490.55	480.16	365.46	381.30

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	6,340.04	4,964.76	4,537.73	4,102.07	3,762.00
Total Assets Growth (%)	27.70	9.41	10.62	9.04	4.83
Total Liabilities	1,973.82	1,625.27	1,243.49	971.51	806.79
Total Liabilities Growth (%)	21.45	30.70	28.00	20.42	11.36
Total Equity	4,366.22	3,339.49	3,294.24	2,756.18	2,955.21
Total Equity Growth (%)	30.75	1.37	19.52	-6.73	3.18
Current Ratio (x)	2.39	3.83	3.82	0.78	0.58
Total Debt to Equity (x)	0.07	0.11	0.12	0.12	0.07
Contingent Liabilities	0.00	324.46	206.11	490.33	397.24

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	655.92	425.05	157.81	1,833.98	1,313.46
Net Cash used in Investing Activities	-288.21	6,014.87	-884.65	-971.88	-570.48
Net Cash flow from Financing Activities	-304.34	-6,357.81	1,052.83	-817.39	-685.42
Net Cash Flow	63.48	82.36	332.39	65.74	64.78
Closing Cash & Cash Equivalent	228.07	164.59	697.46	365.07	299.33
Closing Cash & Cash Equivalent Growth (%)	38.57	-76.40	91.05	21.96	27.62
Total Debt/ CFO (x)	1.07	1.51	4.24	1.25	1.67

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	387.13	367.23	412.75	245.86	31.94
Net Cash used in Investing Activities	-143.59	6,023.00	-342.32	-331.95	-3.35
Net Cash flow from Financing Activities	-243.94	-6,298.11	-67.09	92.20	-17.11
Net Cash Flow	-0.40	92.12	3.34	6.11	11.48
Closing Cash & Cash Equivalent	119.44	119.84	27.72	24.38	18.27
Closing Cash & Cash Equivalent Growth (%)	-0.33	332.32	13.70	33.44	169.07
Total Debt/ CFO (x)	0.81	1.03	0.94	1.38	6.19

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	8.48	156.87	2.83	10.43	13.30
Return on Capital Employed (%)	10.68	11.59	5.71	8.44	9.93
Return on Assets (%)	4.78	81.40	0.71	2.85	4.19
Interest Coverage Ratio (x)	8.35	7.37	5.47	4.99	5.97
Asset Turnover Ratio (x)	0.63	0.34	0.23	0.18	0.14
Price to Earnings (x)	90.09	4.50	158.73	28.41	18.62
Price to Book (x)	7.60	7.06	4.48	2.96	2.48
EV/EBITDA (x)	33.54	25.97	35.61	8.72	7.91
EBITDA Margin (%)	22.11	22.05	16.29	13.77	14.96

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	6.13	185.92	4.76	6.28	3.05
Return on Capital Employed (%)	9.65	133.16	7.06	6.33	3.91
Return on Assets (%)	4.22	125.06	3.45	4.22	2.39
Interest Coverage Ratio (x)	8.08	72.40	5.22	6.53	5.29
Asset Turnover Ratio (x)	0.46	0.49	0.47	0.39	0.30
Price to Earnings (x)	131.58	3.90	131.58	69.93	108.70
Price to Book (x)	7.97	7.25	6.20	4.38	3.31
EV/EBITDA (x)	48.18	3.76	50.82	36.59	42.80
EBITDA Margin (%)	26.96	266.97	20.08	22.04	20.84

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
43%
Positive Movement
since 1st Jan 2005
on basis
56%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 832.28 Pivot
819.17
S1 801.83
R2 849.62 S2 788.72
R3 880.07 S3 758.27
Average True Range
5 Days 14 Days 28 Days
28.11 25.62 24.46

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Aster DM Health	108.79	8.74	8.48	10.68	4.78	-26.28	16.41	9.99	7.53	1.99	0.15	1.07
Narayana Hruday	48.04	8.53	17.75	11.91	6.45	20.10	16.07	10.20	39.67	2.15	1.07	3.01
Global Health	59.66	8.33	14.04	15.06	9.42	17.59	18.02	12.56	20.71	2.67	0.30	1.67
Krishna Instt of Medical Sciences	130.14	12.28	10.74	8.35	3.11	20.68	13.95	6.13	6.03	0.76	1.44	6.35
Dr. Agarwals Health	104.60	6.57	6.57	9.70	3.37	26.93	16.23	8.08	4.21	1.24	0.08	0.30
Add More

Annual Ratios (%)

Choose from Peers

Rainbow Childrens
Healthcare Global
Jupiter Life Line Hospitals
Yatharth Hospital
Artemis Medicare

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Found Peer Comparison useful?

Shareholding Pattern

Total Shareholdings

Category	No. of Shares	Percentage	% Change QoQ
Promoters	20,92,83,923	40.39 %	0.00
Pledge	8,50,96,820	40.66 %	0.00
FII	8,90,27,972	17.18 %	-1.28
DII	14,28,70,581	27.57 %	1.44
MF	13,70,30,263	26.45 %	1.84
Others	7,69,38,553	14.86 %	-0.17

QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 40.39 40.39 40.39 40.39
Pledge 40.66 40.66 40.66 40.67
FII 17.18 18.46 18.72 19.64
DII 27.57 26.12 26.32 25.28
Mutual Funds 26.45 24.60 24.89 23.87
Others 14.86 15.03 14.56 14.68

Mutual Funds Ownership

MF Ownership as on 30 April 2026

HDFC Small Cap Direct-G
Equity: Small Cap
4
- 1,687.22
  Amount Invested (in Cr.)
- 4.42%
  % of AUM
- 0.00
  % Change (MoM basis)
Kotak Small Cap Direct-G
Equity: Small Cap
2
- 794.10
  Amount Invested (in Cr.)
- 4.56%
  % of AUM
- -3.66
  % Change (MoM basis)
Quant Small Cap Direct-G
Equity: Small Cap
3
- 792.55
  Amount Invested (in Cr.)
- 2.609325%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Aster DM Health Top Searches

Corporate Actions

Recent
Board Meeting
Audited Results
Apr 27, 2026
Board Meeting
Interim Dividend
Mar 20, 2026
Interim Dividend
30%
Mar 20, 2026

Announced on	Meeting on
Apr 27, 2026	Apr 30, 2026
Audited Results
Mar 20, 2026	Mar 26, 2026
Interim Dividend
Jan 23, 2026	Jan 30, 2026
Quarterly Results & ESOP
Oct 31, 2025	Nov 06, 2025
Quarterly Results & ESOP
Jul 25, 2025	Jul 30, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
Mar 20, 2026 Apr 02, 2026 30%
May 20, 2025 Aug 28, 2025 10%
Jan 27, 2025 Feb 10, 2025 40%
May 28, 2024 Aug 22, 2024 20%
Apr 05, 2024 Apr 23, 2024 1180%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Mar 16, 2026 Apr 14, 2026
-
Feb 05, 2026 Mar 10, 2026
-
Aug 18, 2025 Sep 04, 2025
-
Dec 02, 2024 Dec 31, 2024
-
May 28, 2024 -
-

About Aster DM Health

Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 42,224.27 Crore) operating in Hospitals & Allied Services sector.

Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services and Consultancy Income for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 1,218.58 Crore, up .40 % from last quarter Total Income of Rs 1,213.73 Crore and up 18.12 % from last year same quarter Total Income of Rs 1,031.62 Crore. Company has reported net profit after tax of Rs 162.11 Crore in latest quarter.

The company’s top management includes Dr.Azad Moopen, Ms.Alisha Moopen, Dr.Harsha Rajaram, Dr.N Prashanth, Mr.Anoop Moopen, Mr.Daniel Robert Mintz, Mr.Shamsudheen Bin Mohideen Mammu Haji, Mr.T J Wilson, Dr.Zeba Azad Moopen, Mr.Chenayappillil John George, Mr.Emmanuel David Gootam, Dr.James Mathew, Mr.Maniedath Madhavan Nambiar, Ms.Purana Housdurgamvijaya Deepti, Mr.Sunil Theckath Vasudevan, Mr.M R Sunil Kumar, Mr.S Ramesh Kumar, Mr.Hemish Purushottam. Company has Deloitte Haskins & Sells as its auditors. As on 31-03-2026, the company has a total of 51.81 Crore shares outstanding.

Aster DM Health Share Price Today is Rs. 814.95. On previous day, the Aster DM Health Share Price (NSE) closed at Rs. 813.75, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 40.39% of the stake in Aster DM Health shares, out of which 40.66% was pledged. On the same date, foreign institutional investors' (FII) holdings of Aster DM Health stocks was 17.18% as compared to 18.46% in Dec 2025 with decrease of 1.28%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 27.57% as compared to 26.12% in Dec 2025 with increase of 1.45%. Out of the total DII holdings in Aster DM Health shares 26.45% was held by mutual funds. The rest including public held is 14.86%. Aster DM Health stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Aster DM Health Dividend: Ever since 2008, Aster DM Health dividends has been paid out around 6 times. As on 12 Jun, 2026, 03:58 PM IST, The overall dividend yield for Aster DM Health stands at 0.0%. The last dividend paid was on April 2, 2026 (Rs. 3.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 7.49.

Aster DM Health Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 1218.58 Cr. of sales and 0.4% of quarterly net profit, there have been multiple ups and downs in the Aster DM Health stock prices in the past few weeks. For example, Aster DM Health stock price on 5th of June 2026 was around Rs. 754.0. Aster DM Health share price now stands at an average of Rs. 814.95. Judging by last week's performance, stock is in up trend.

Aster DM Health has a median target price of Rs. 797.7 in 12 months by 10 analysts. They have provided a high estimate of Rs. 890.0 and low estimate of Rs. 736.0 for Aster DM Health share.

Historical Prices and Performance:
Aster DM Health, incorporated in 2008 is a Mid Cap company (with a market cap of Rs. 42224.27) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Aster DM Health stock was 8.48%, 156.87%, 2.83%, 10.43% and 13.3% respectively.
The Aster DM Health share gave a 3 year return of 192.1% as compared to Nifty 50 which gave a return of 26.99%.
Aster DM Health announced 30.0% final dividend on April 2, 2026.

Key Metrics:
PE Ratio of Aster DM Health is 108.79
Prices/Sales Ratio of Aster DM Health is 7.49
Price/Book Ratio of Aster DM Health is 8.74

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Aster DM Health, major competitors and peers include Narayana Hruday, Global Health, Krishna Instt of Medical Sciences and Dr. Agarwals Health. As of Dec 2025, the dividend yield of Aster DM Health stands at 0.0% while Narayana Hruday, Global Health, Krishna Instt of Medical Sciences and Dr. Agarwals Health stand at 0.24%, 0.0%, 0.0% and 0.0% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 108.79 and 8.74 respectively.

Leadership of Aster DM Health :
N Prashanth is CEO - Karnataka Cluster
Hemish Purushottam is Co. Secretary & Compl. Officer
M R Sunil Kumar is Chief Financial Officer
T J Wilson is Group Head - Governance & Corporate Affairs
Harsha Rajaram is CEO - Aster Digital Health
Durga Prasanna is Head - Human Resource
S Ramesh Kumar is Chief Operating Officer
Azad Moopen is Founder Chairman & Mng. Director
Alisha Moopen is Deputy Managing Director
Daniel Robert Mintz is Non Executive Director
T J Wilson is Non Executive Director
Shamsudheen Bin Mohideen Mammu Haji is Non Executive Director
Zeba Azad Moopen is Non Executive Director
Anoop Moopen is Non Executive Director
Purana Housdurgamvijaya Deepti is Independent Director
Chenayappillil John George is Independent Director
Maniedath Madhavan Nambiar is Independent Director
Sunil Theckath Vasudevan is Independent Director
James Mathew is Independent Director
Emmanuel David Gootam is Independent Director

Show More

Industry

Key Indices Listed On

Nifty Smallcap 100, Nifty 500, BSE 500, BSE 250 SmallCap Index, BSE SmallCap

Address

Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama Nagar,Bengaluru, Kerala - 560027

Contact

cs@asterdmhealthcare.com

http://www.asterdmhealthcare.in

Executive Leadership

AM

Azad Moopen

Founder Chairman & Mng. Director

AM

Alisha Moopen

Deputy Managing Director

HR

Harsha Rajaram

CEO - Aster Digital Health

NP

N Prashanth

CEO - Karnataka Cluster

Show More

Auditors

Deloitte Haskins & Sells

FAQs about Aster DM Health share

1. What's Aster DM Health share price today and what are Aster DM Health share returns ?
Aster DM Health share price is Rs 814.95 as on 12 Jun, 2026, 03:58 PM IST. Aster DM Health share price is up by 0.15% based on previous share price of Rs 812.9. Aster DM Health share price trend:
- Last 12 Months: Aster DM Health share price moved up 44.41%
- Last 3 Years: Aster DM Health Share price moved up by 192.10%
2. What has been highest price of Aster DM Health share in last 52 weeks?
Aster DM Health share price saw a 52 week high of Rs 836.50 and 52 week low of Rs 519.10.
3. What's the market capitalization of Aster DM Health?
Within the Hospitals & Allied Services sector, Aster DM Health stock has a market cap rank of 4. Aster DM Health has a market cap of Rs 42,224.27 Cr.
4. What are the returns for Aster DM Health share?
Return Performance of Aster DM Health Shares:
- 1 Week: Aster DM Health share price moved up by 8.08%
5. What is the PE & PB ratio of Aster DM Health?
The PE ratio of Aster DM Health stands at 108.63, while the PB ratio is 11.13.

Top Gainers

As on 04:06 PM | 12 Jun 2026

1,028.70

714.90 (227.82%)

Netweb Technologies

4,587.40

2780.60 (153.90%)

Syrma SGS Technology

1,266.70

737.70 (139.45%)

14.90

8.12 (119.76%)

4,942.50

2633.90 (114.09%)

Top Losers

As on 03:58 PM | 12 Jun 2026

Tata Investment

665.90

-6218.10 (-90.33%)

339.50

-2678.10 (-88.75%)

757.55

-3315.15 (-81.40%)

403.30

-1723.50 (-81.04%)

Authum Investment

530.15

-1967.65 (-78.78%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.